Table 2.
Author, year | Country | SV40 DNA by PCR [no. positive/no. tested (%)]
|
|
---|---|---|---|
Lymphoma | Control | ||
Amara et al., 2007 | Tunisia | 63/108 (56) | 4/60 (6)b |
Zekri et al., 2007 | Egypt | 85/158 (54) | 4/34 (12)b |
Shivapurkar et al., 2002 | US | 29/68 (43) | 5/120 (4.2) |
Vilchez et al., 2002 | US | 64/154 (42) | 0/240 (0) |
Shivapurkar et al., 2004 | US | 33/90 (36) | 1/56 (1.2) |
Meneses et al., 2005 | Costa Rica | 30/125 (24) | 0/91 (0) |
Vilchez et al., 2005 | US | 12/55 (22) | 0/19 (0) |
David et al., 2001 | US | 15/79 (19) | 19/187 (10)b |
Martini et al., 1998 | Italy | 11/79 (14) | 3/50 (6)b |
Chen et al., 2006 | Taiwan | 13/91 (14) | 0/106 (0) |
Nakatsuka et al., 2003 | Japan | 14/122 (11) | 3/64 (4.7)b |
Capello et al., 2003 | Spain, Italy | 17/500 (3) | 0/15 (0) |
Daibata et al., 2003 | Japan | 3/125 (2) | 0/31 (0) |
MacKenzie et al., 2003 | UK | 0/152 (0) | 0/45 (0) |
Sui et al., 2005 | Tasmania | 0/50 (0) | 0/50 (0) |
Schüler et al., 2006 | Germany | 0/77 (0) | 0/61 (0) |
TOTAL | 389/2033 (19.1)c | 39/1207 (3.2)b,c |
See Butel [34] for original references.
Among control samples positive for SV40 were 28 blood samples from noncancer patients or healthy individuals.
p<0.001 (Z test of proportions).